Search PubMed⌕ Search

PubMed · 12496732

Human mate guarding.

Abstract

Long-term committed mating is a fundamental strategy in the human repertoire. Successful enactment of this strategy requires solving two related adaptive problems--fending off potential mate poachers and preventing a mates from defecting. Mate guarding adaptations evolved to solve these persistent problems. Those who failed in mate guarding risked suffering substantial reproductive costs ranging from genetic cuckoldry to reputational damage to the entire loss of a mate. Because the precise nature of the adaptive problems confronted differed historically for the sexes, men and women evolved corresponding differences in the underlying psychology of mate guarding. Men's mate guarding, relative to that of women's, is strongly triggered as a consequence of being mated to young and physically attractive women, being confronted by interested rivals who have superior economic resources or prospects, and having a mate who displays signs of sexual involvement with a rival. Women's mate guarding, relative to that of men's, is triggered as a consequence of being mated to men high in income and status striving, rivals who are more physically attractive, and having a partner who shows signs of emotional involvement with another woman. Behavioral output of mate guarding adaptations range from vigilance to violence.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

David M Buss. 2002. Human mate guarding.. https://pubmed.ncbi.nlm.nih.gov/12496732/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Behavioral and pharmacologic therapy of obstructive sleep apnea.

Previous attempts at using pharmacologic agents in the treatment of OSA have been disappointing. Medroxyprogesterone has not been found to be useful in the treatment of OSA. Use of protriptyline is limited by frequent side effects, but its role in mild and REM-related OSA must be clarified. SSRIs seem to be ineffective in treatment of severe OSA. Further studies are needed to determine their effect in persons with mild disease. This is important because patients with mild OSA (AHI < 15 hours) are most likely to be noncompliant with CPAP therapy [91]. A recent systematic review of drug treatments for OSA concluded that the current data do not support the use of any drug as an alternative to CPAP [92]. Of 56 studies identified, only 9 studies met methodologic criteria. Clearly, basic research and adequately powered clinical trials are needed to identify an effective medication for OSA.

Behavior Control↗